Cargando…

Do Nonventilatory Strategies for Acute Lung Injury and ARDS Work?

Detalles Bibliográficos
Autores principales:	Sweeney, Rob Mac, McAuley, Danny F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151787/ http://dx.doi.org/10.1016/B978-1-4160-5476-4.00012-2

Ejemplares similares

Pharmacological treatments in ARDS; a state-of-the-art update
por: Boyle, Andrew James, et al.
Publicado: (2013)

KL-6 in acute lung injury: will it leave its mark?
por: Shyamsundar, Murali, et al.
Publicado: (2008)

Acute respiratory distress syndrome
por: Sweeney, Rob Mac, et al.
Publicado: (2016)

Nonventilatory factors affecting noninvasive mechanical ventilation success in hypercapnic critical care patients
por: Demir, S, et al.
Publicado: (2014)

Beta 2 antagonism in acute respiratory failure
por: Sweeney, Rob Mac, et al.
Publicado: (2010)

Human models of acute lung injury
por: Proudfoot, Alastair G., et al.
Publicado: (2011)

Cytokine adsorption during ECMO for COVID-19-related ARDS
por: Shekar, Kiran, et al.
Publicado: (2021)

Vascular risk factors for COVID-19 ARDS: endothelium, contact-kinin system
por: Bailey, Melanie, et al.
Publicado: (2023)

Re-analysis of ventilator-free days (VFD) in acute respiratory distress syndrome (ARDS) studies
por: Verghis, Rejina Mariam, et al.
Publicado: (2023)

Evidence for chemokine synergy during neutrophil migration in ARDS
por: Williams, Andrew E, et al.
Publicado: (2017)

Fluid management in acute lung injury and ards
por: Roch, Antoine, et al.
Publicado: (2011)

Effect of sustained inflation recruitment maneuvers on lung endothelial and alveolar epithelial injury in experimental acute lung injury
por: Frank, J, et al.
Publicado: (2004)

Emerging pharmacological therapies for ARDS: COVID-19 and beyond
por: Horie, Shahd, et al.
Publicado: (2020)

Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS
por: Dutra Silva, Johnatas, et al.
Publicado: (2021)

Hyperoxaemia and hypoxaemia are associated with harm in patients with ARDS
por: Boyle, Andrew J., et al.
Publicado: (2021)

Acute Respiratory Distress Syndrome Subphenotypes beyond the Syndrome: A Step toward Treatable Traits?
por: Reddy, Kiran, et al.
Publicado: (2021)

Promises and challenges of personalized medicine to guide ARDS therapy
por: Wick, Katherine D., et al.
Publicado: (2021)

Type XVIII collagen degradation products in acute lung injury
por: Perkins, Gavin D, et al.
Publicado: (2009)

Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome
por: Toner, Philip, et al.
Publicado: (2015)

Simvastatin decreases the level of heparin-binding protein in patients with acute lung injury
por: McAuley, Daniel F, et al.
Publicado: (2013)

ARDS associated acute brain injury: from the lung to the brain
por: Ziaka, Mairi, et al.
Publicado: (2022)

Effects of an open lung approach following the ARDS Network ventilatory strategy in patients with early acute lung injury/acute respiratory distress syndrome
por: Rotman, V, et al.
Publicado: (2008)

Comparison of thermodilution measured extravascular lung water with chest radiographic assessment of pulmonary oedema in patients with acute lung injury
por: Brown, Lisa M, et al.
Publicado: (2013)

Extracorporeal membrane oxygenation (ECMO) and the acute respiratory distress syndrome (ARDS): a systematic review of pre-clinical models
por: Millar, Jonathan E., et al.
Publicado: (2019)

TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial
por: Ware, Lorraine B, et al.
Publicado: (2023)

Towards a biological definition of ARDS: are treatable traits the solution?
por: Bos, Lieuwe D. J., et al.
Publicado: (2022)

Gaining muscle mass in COPD: a work in progress
por: McAuley, Hamish J.C., et al.
Publicado: (2023)

Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials
por: Santhakumaran, Shalini, et al.
Publicado: (2019)

Acute Lung Injury- ARDS in H1N1: Timing of Therapy
por: Boran, Ertay, et al.
Publicado: (2015)

Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis
por: Boyle, Andrew J, et al.
Publicado: (2015)

Acute right ventricular injury phenotyping in ARDS
por: Zochios, Vasileios, et al.
Publicado: (2022)

ROS Signaling in the Pathogenesis of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS)
por: Kellner, Manuela, et al.
Publicado: (2017)

Acute Respiratory Distress Syndrome
por: Adams, Claire E., et al.
Publicado: (2022)

Comparing regression and neural network techniques for personalized predictive analytics to promote lung protective ventilation in Intensive Care Units
por: Hagan, Rachael, et al.
Publicado: (2020)

Automated mechanical ventilation based on the ARDS Network protocol in porcine acute lung injury
por: Meier, T, et al.
Publicado: (2007)

Effect of prone position on pulmonary vascular permeability in acute respiratory distress syndrome
por: McAuley, D, et al.
Publicado: (2001)

Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol
por: Cross, Laurence JM, et al.
Publicado: (2013)

Reply to Aberegg and Wolfe: Aspergillosis in the ICU: Hidden Enemy or Bogeyman?
por: Loughlin, Laura, et al.
Publicado: (2021)

Decreased respiratory system compliance on the sixth day of mechanical ventilation is a predictor of death in patients with established acute lung injury
por: Seeley, Eric J, et al.
Publicado: (2011)

Relation between functional connectivity and rhythm discrimination in children who do and do not stutter
por: Chang, Soo-Eun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3rs99ba5edcr271ohnnmtg0k90